GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


SELECTING OUTCOMES: SURROGATE ENDPOINTS


OBJECTIVES

Surrogate endpoints are increasingly used in clinical trials as the principal variable to assess medicine efficacy.

This course intends to make you qualified on the advantages and limitations of use, clinical meaningful and usefulness of surrogate endpoints in order to assess new drug efficacy in some clinical areas with increasing drug innovation (such as diabetes or multiple sclerosis).

Surrogate endpoints, Variable, Advantages, Limitations, Use

 

LEARNING OUTCOMES

At then end of this course, you will be familiar with the advantages and limitations of using surrogate endpoints as principal variables in clinical trials and with their correlation with the clinical main outcomes.

 

120 minutes
Online based learning
English language
Certificate of Achievement
500 €
BOOK NOW

AUTHORS

avatar

Josep Maria Castel

Universitat Autònoma de Barcelona

avatar

Dr. Antònia Agustí

Universitat Autònoma de Barcelona


avatar

Dr. Xavier Vidal

Universitat Autònoma de Barcelona

avatar

Dr. Montse Bosche

Universitat Autònoma de Barcelona




COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners